BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10676433)

  • 1. Stress, corticotropin-releasing factor, and drug addiction.
    Koob GF
    Ann N Y Acad Sci; 1999; 897():27-45. PubMed ID: 10676433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors.
    Koob GF; Heinrichs SC
    Brain Res; 1999 Nov; 848(1-2):141-52. PubMed ID: 10612706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention.
    Logrip ML; Koob GF; Zorrilla EP
    CNS Drugs; 2011 Apr; 25(4):271-87. PubMed ID: 21425881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of CRF and CRF-related peptides in the dark side of addiction.
    Koob GF
    Brain Res; 2010 Feb; 1314():3-14. PubMed ID: 19912996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence.
    Bruijnzeel AW; Gold MS
    Brain Res Brain Res Rev; 2005 Nov; 49(3):505-28. PubMed ID: 16269317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism.
    Lowery EG; Thiele TE
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):77-86. PubMed ID: 20201818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin releasing factor: a key role in the neurobiology of addiction.
    Zorrilla EP; Logrip ML; Koob GF
    Front Neuroendocrinol; 2014 Apr; 35(2):234-44. PubMed ID: 24456850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurobiology of stress and cocaine addiction. Studies on corticotropin-releasing factor in rats, monkeys, and humans.
    Sarnyai Z
    Ann N Y Acad Sci; 1998 Jun; 851():371-87. PubMed ID: 9668628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticotropin-releasing factor in the dorsal raphe nucleus: Linking stress coping and addiction.
    Valentino RJ; Lucki I; Van Bockstaele E
    Brain Res; 2010 Feb; 1314():29-37. PubMed ID: 19800322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Region-specific roles of the corticotropin-releasing factor-urocortin system in stress.
    Henckens MJ; Deussing JM; Chen A
    Nat Rev Neurosci; 2016 Oct; 17(10):636-51. PubMed ID: 27586075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin.
    Martin-Fardon R; Zorrilla EP; Ciccocioppo R; Weiss F
    Brain Res; 2010 Feb; 1314():145-61. PubMed ID: 20026088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of corticotropin-releasing factor in drug addiction.
    Sarnyai Z; Shaham Y; Heinrichs SC
    Pharmacol Rev; 2001 Jun; 53(2):209-43. PubMed ID: 11356984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking.
    Shalev U; Erb S; Shaham Y
    Brain Res; 2010 Feb; 1314():15-28. PubMed ID: 19631614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of early life social adversity on drug abuse vulnerability: Focus on corticotropin-releasing factor and oxytocin.
    Bardo MT; Hammerslag LR; Malone SG
    Neuropharmacology; 2021 Jun; 191():108567. PubMed ID: 33862030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of corticotropin-releasing factor family peptides and receptors in stress-related psychiatric disorders.
    Clark MS; Kaiyala KJ
    Semin Clin Neuropsychiatry; 2003 Apr; 8(2):119-36. PubMed ID: 12728411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin-Releasing Factor (CRF) Neurocircuitry and Neuropharmacology in Alcohol Drinking.
    Schreiber AL; Gilpin NW
    Handb Exp Pharmacol; 2018; 248():435-471. PubMed ID: 29374836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of withdrawal in reinstatement of morphine-conditioned place preference.
    Lu L; Chen H; Su W; Ge X; Yue W; Su F; Ma L
    Psychopharmacology (Berl); 2005 Aug; 181(1):90-100. PubMed ID: 15739075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin-releasing factor, norepinephrine, and stress.
    Koob GF
    Biol Psychiatry; 1999 Nov; 46(9):1167-80. PubMed ID: 10560023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor.
    Koob GF; Zorrilla EP
    Curr Opin Investig Drugs; 2010 Jan; 11(1):63-71. PubMed ID: 20047160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides.
    Boorse GC; Denver RJ
    Gen Comp Endocrinol; 2006 Mar; 146(1):9-18. PubMed ID: 16413023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.